165 related articles for article (PubMed ID: 34109623)
1. Dual Functions of Riboflavin-functionalized Poly(lactic-co-glycolic acid) Nanoparticles for Enhanced Drug Delivery Efficiency and Photodynamic Therapy in Triple-negative Breast Cancer Cells.
Mekseriwattana W; Phungsom A; Sawasdee K; Wongwienkham P; Kuhakarn C; Chaiyen P; Katewongsa KP
Photochem Photobiol; 2021 Nov; 97(6):1548-1557. PubMed ID: 34109623
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
4. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line.
Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC
Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059
[No Abstract] [Full Text] [Related]
5. Using anti-PD-L1 antibody conjugated gold nanoshelled poly (Lactic-co-glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer.
Jiang H; Zhou Y; Zheng D; Cheng Y; Xiang D; Jiang L; Du J
J Biomed Mater Res A; 2024 Mar; 112(3):402-420. PubMed ID: 37941485
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.
Dinakar YH; Rajana N; Kumari NU; Jain V; Mehra NK
AAPS PharmSciTech; 2023 Dec; 24(8):258. PubMed ID: 38097825
[TBL] [Abstract][Full Text] [Related]
7. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy.
Deepika MS; Thangam R; Sheena TS; Vimala RTV; Sivasubramanian S; Jeganathan K; Thirumurugan R
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109716. PubMed ID: 31349431
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R
Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
12. ICG/l-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissues.
Sun Z; Wang X; Liu J; Wang Z; Wang W; Kong D; Leng X
Mol Pharm; 2021 Mar; 18(3):928-939. PubMed ID: 33427470
[TBL] [Abstract][Full Text] [Related]
13. Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer.
Chaudhari D; Kuche K; Yadav V; Ghadi R; Date T; Bhargavi N; Jain S
Drug Deliv Transl Res; 2023 Apr; 13(4):1074-1087. PubMed ID: 36528709
[TBL] [Abstract][Full Text] [Related]
14. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy.
Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R
Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
16. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
17. Shifting the absorption to the near-infrared region and inducing a strong photothermal effect by encapsulating zinc(II) phthalocyanine in poly(lactic-co-glycolic acid)-hyaluronic acid nanoparticles.
Gao D; Wong RCH; Wang Y; Guo X; Yang Z; Lo PC
Acta Biomater; 2020 Oct; 116():329-343. PubMed ID: 32890751
[TBL] [Abstract][Full Text] [Related]
18. Formulation of Carnosic-Acid-Loaded Polymeric Nanoparticles: An Attempt to Endorse the Bioavailability and Anticancer Efficacy of Carnosic Acid against Triple-Negative Breast Cancer.
Chatterjee S; Chakraborty P; Dutta S; Karak S; Mahalanobis S; Ghosh N; Dewanjee S; Sil PC
ACS Appl Bio Mater; 2024 Mar; 7(3):1656-1670. PubMed ID: 38364267
[TBL] [Abstract][Full Text] [Related]
19. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.
Cerqueira BBS; Lasham A; Shelling AN; Al-Kassas R
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():593-600. PubMed ID: 28482569
[TBL] [Abstract][Full Text] [Related]
20. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]